$USNA
USANA Health Sciences Inc

2020 Q1 Form 10-Q Financial Statement

#000156276220000164 Filed on May 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $266.6M $273.0M
YoY Change -2.33% -6.51%
Cost Of Revenue $46.06M $45.90M
YoY Change 0.34% -7.04%
Gross Profit $220.6M $227.1M
YoY Change -2.88% -6.4%
Gross Profit Margin 82.72% 83.19%
Selling, General & Admin $65.48M $69.56M
YoY Change -5.86% -0.82%
% of Gross Profit 29.69% 30.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.494M $3.866M
YoY Change -9.62% -14.68%
% of Gross Profit 1.58% 1.7%
Operating Expenses $181.5M $192.1M
YoY Change -5.49% -3.71%
Operating Profit $39.01M $35.00M
YoY Change 11.45% -18.84%
Interest Expense $21.00K $12.00K
YoY Change 75.0% 20.0%
% of Operating Profit 0.05% 0.03%
Other Income/Expense, Net $151.0K $1.290M
YoY Change -88.29% 49.65%
Pretax Income $39.16M $36.29M
YoY Change 7.9% -17.5%
Income Tax $12.61M $12.12M
% Of Pretax Income 32.2% 33.4%
Net Earnings $26.55M $24.17M
YoY Change 9.85% -16.49%
Net Earnings / Revenue 9.96% 8.85%
Basic Earnings Per Share $1.24 $1.03
Diluted Earnings Per Share $1.23 $1.01
COMMON SHARES
Basic Shares Outstanding 21.50M 23.48M
Diluted Shares Outstanding 21.55M 23.93M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $194.1M $251.9M
YoY Change -22.95% -5.37%
Cash & Equivalents $194.1M $225.0M
Short-Term Investments $26.90M
Other Short-Term Assets $32.10M $31.80M
YoY Change 0.94% 0.0%
Inventory $60.57M $86.47M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $286.8M $370.2M
YoY Change -22.53% 1.11%
LONG-TERM ASSETS
Property, Plant & Equipment $97.25M $91.99M
YoY Change 5.71% -9.28%
Goodwill $16.49M $17.07M
YoY Change -3.4%
Intangibles $29.07M $32.23M
YoY Change -9.79%
Long-Term Investments
YoY Change
Other Assets $41.42M $36.86M
YoY Change 12.37% 49.23%
Total Long-Term Assets $187.0M $181.4M
YoY Change 3.08% 0.89%
TOTAL ASSETS
Total Short-Term Assets $286.8M $370.2M
Total Long-Term Assets $187.0M $181.4M
Total Assets $473.8M $551.6M
YoY Change -14.11% 1.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.82M $11.70M
YoY Change 1.06% -7.87%
Accrued Expenses $6.800M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $124.5M $130.0M
YoY Change -4.22% 2.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $17.91M $12.87M
YoY Change 39.18% 1069.73%
Total Long-Term Liabilities $17.91M $12.87M
YoY Change 39.18% 1069.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $124.5M $130.0M
Total Long-Term Liabilities $17.91M $12.87M
Total Liabilities $142.4M $142.9M
YoY Change -0.31% -1.48%
SHAREHOLDERS EQUITY
Retained Earnings $284.7M $329.0M
YoY Change -13.47%
Common Stock $52.03M $69.12M
YoY Change -24.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $317.6M $391.2M
YoY Change
Total Liabilities & Shareholders Equity $473.8M $551.6M
YoY Change -14.11% 1.04%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $26.55M $24.17M
YoY Change 9.85% -16.49%
Depreciation, Depletion And Amortization $3.494M $3.866M
YoY Change -9.62% -14.68%
Cash From Operating Activities $30.79M $5.521M
YoY Change 457.62% -71.71%
INVESTING ACTIVITIES
Capital Expenditures $7.266M $2.577M
YoY Change 181.96% -12.58%
Acquisitions
YoY Change
Other Investing Activities -$1.000M $35.10M
YoY Change -102.85% 11600.0%
Cash From Investing Activities -$8.270M $32.51M
YoY Change -125.44% -1344.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $57.03M $30.00M
YoY Change 90.1% 919.37%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$58.85M -31.41M
YoY Change 87.35% 866.26%
NET CHANGE
Cash From Operating Activities $30.79M 5.521M
Cash From Investing Activities -$8.270M 32.51M
Cash From Financing Activities -$58.85M -31.41M
Net Change In Cash -$40.77M 10.79M
YoY Change -477.97% -43.74%
FREE CASH FLOW
Cash From Operating Activities $30.79M $5.521M
Capital Expenditures $7.266M $2.577M
Free Cash Flow $23.52M $2.944M
YoY Change 698.91% -82.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-02
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000896264
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-28
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-35024
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
USANA HEALTH SCIENCES, INC.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0500306
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3838 West Parkway Blvd.
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84120
CY2020Q1 dei City Area Code
CityAreaCode
801
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
954-7100
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2020Q1 dei Trading Symbol
TradingSymbol
USNA
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21014330
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
194098000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234830000
CY2020Q1 us-gaap Inventory Net
InventoryNet
60568000
CY2019Q4 us-gaap Inventory Net
InventoryNet
68905000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32097000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25544000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
286763000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
329279000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97246000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
95233000
CY2020Q1 us-gaap Goodwill
Goodwill
16493000
CY2019Q4 us-gaap Goodwill
Goodwill
16636000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29071000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29840000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12525000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
59445000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
284682000
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2756000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3090000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41421000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42856000
CY2020Q1 us-gaap Assets
Assets
473750000
CY2019Q4 us-gaap Assets
Assets
516934000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11824000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
112680000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
123573000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
124504000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
136098000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
13730000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10282000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17908000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18842000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20995000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20995000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21655000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21655000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
21000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
22000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
52004000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
306146000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19099000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13901000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
317608000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
351712000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
473750000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
516934000
CY2020Q1 us-gaap Revenues
Revenues
266619000
CY2019Q1 us-gaap Revenues
Revenues
272990000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46059000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45901000
CY2020Q1 us-gaap Gross Profit
GrossProfit
220560000
CY2019Q1 us-gaap Gross Profit
GrossProfit
227089000
CY2020Q1 usna Associate Incentives
AssociateIncentives
116069000
CY2019Q1 usna Associate Incentives
AssociateIncentives
122530000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65479000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
69555000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
181548000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
192085000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
39012000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
35004000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
984000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1484000
CY2020Q1 us-gaap Interest Expense
InterestExpense
21000
CY2019Q1 us-gaap Interest Expense
InterestExpense
12000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-812000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-182000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
151000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1290000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
39163000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
36294000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12611000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12122000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
26552000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
24172000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21497000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23484000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21551000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23927000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
26552000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
24172000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-6237000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
4774000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1039000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1294000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5198000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3480000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21354000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27652000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
391146000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
24172000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3480000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3832000
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
30000000
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1413000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
391217000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
351712000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
26552000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5198000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3394000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
57029000
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1823000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
317608000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
26552000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
24172000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3494000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3866000
CY2020Q1 usna Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
2255000
CY2019Q1 usna Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
2023000
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3394000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3832000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4611000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3048000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5153000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3630000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4262000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1480000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-174000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1750000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10237000
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-31043000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30786000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5521000
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
85000
CY2019Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
55000
CY2020Q1 us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
1089000
CY2019Q1 us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
1660000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
36685000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7266000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2577000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8270000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32509000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
57029000
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
5000000
CY2019Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5000000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1823000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1413000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58852000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31413000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4436000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4170000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40772000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10787000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237688000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217234000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196916000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
228021000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
194098000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225041000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2818000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2980000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196916000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
228021000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
2000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
5000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
9694000
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
10163000
CY2019Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
5095000
CY2020Q1 usna Noncash Right Of Use Asset Obtained In Exchange For Operating Lease Liability
NoncashRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1914000
CY2019Q1 usna Noncash Right Of Use Asset Obtained In Exchange For Operating Lease Liability
NoncashRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20286000
CY2020Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
608000
CY2019Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
251000
CY2020Q1 usna Number Of Geographic Regions
NumberOfGeographicRegions
2
CY2020Q1 usna Number Of Sub Geographical Regions
NumberOfSubGeographicalRegions
3
CY2019Q4 usna Nonfinancial Assets Fair Value Disclosure
NonfinancialAssetsFairValueDisclosure
0
CY2020Q1 usna Nonfinancial Assets Fair Value Disclosure
NonfinancialAssetsFairValueDisclosure
0
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14054000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15879000
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9922000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12111000
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
36592000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
40915000
CY2020Q1 us-gaap Inventory Net
InventoryNet
60568000
CY2019Q4 us-gaap Inventory Net
InventoryNet
68905000
CY2020Q1 us-gaap Other Income
OtherIncome
643000
CY2019Q1 us-gaap Other Income
OtherIncome
466000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13852000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15055000
CY2020Q1 usna Contract With Customer Liability Increase Decrease In Deferred Revenue
ContractWithCustomerLiabilityIncreaseDecreaseInDeferredRevenue
13361000
CY2019 usna Contract With Customer Liability Increase Decrease In Deferred Revenue
ContractWithCustomerLiabilityIncreaseDecreaseInDeferredRevenue
13852000
CY2020Q1 usna Contract With Customer Liability Increase Decrease Revenue Recognized
ContractWithCustomerLiabilityIncreaseDecreaseRevenueRecognized
-13132000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
785000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
24172000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21497000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23484000
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14081000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
54000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
443000
CY2019 usna Contract With Customer Liability Increase Decrease Revenue Recognized
ContractWithCustomerLiabilityIncreaseDecreaseRevenueRecognized
-15055000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13852000
CY2020Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
75000000
CY2020Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
90000000
CY2019Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
110000000
CY2020Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
850000
CY2019Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-986000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
26552000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21551000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23927000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
815000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
105000
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
284000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
57029000
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
72971000
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q1 usna Percentage Of Revenue From Major Customer
PercentageOfRevenueFromMajorCustomer
0.10
CY2020Q1 us-gaap Revenues
Revenues
266619000
CY2019Q1 us-gaap Revenues
Revenues
272990000

Files In Submission

Name View Source Status
0001562762-20-000164-index-headers.html Edgar Link pending
0001562762-20-000164-index.html Edgar Link pending
0001562762-20-000164.txt Edgar Link pending
0001562762-20-000164-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usna-20200328.xsd Edgar Link pending
usna-20200328x10q.htm Edgar Link pending
usna-20200328x10q_htm.xml Edgar Link completed
usna-20200328xex31_1.htm Edgar Link pending
usna-20200328xex31_2.htm Edgar Link pending
usna-20200328xex32_1.htm Edgar Link pending
usna-20200328xex32_2.htm Edgar Link pending
usna-20200328_cal.xml Edgar Link unprocessable
usna-20200328_def.xml Edgar Link unprocessable
usna-20200328_lab.xml Edgar Link unprocessable
usna-20200328_pre.xml Edgar Link unprocessable